诱导免疫治疗肺癌后的操作挑战
Andrew Hawkins1, Linda W Martin1
1Division of Cardiothoracic Surgery, Department of Surgery, University of Virginia Health, 1215 Lee Street, Charlottesville, VA 22908, USA.
Thoracic surgery clinics
|July 6, 2025
概括
新辅助免疫疗法和化疗对局部发达的非小细胞肺癌具有前途,可以显著减少瘤. 外科医生必须应对纤维化和改变的平面等潜在的挑战,适应技术以获得最佳的患者结果.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 免疫治疗是一种免疫疗法.
背景情况:
- 新辅助药检查点抑制与化疗相结合,为局部发达的非小细胞肺癌提供了有希望的病理完整反应率 (17%-41%).
- 仅新辅助免疫疗法就会在30%-65%的患者中产生重大病理反应,这意味着巨大的瘤减少.
研究的目的:
- 评估新辅助免疫疗法和化疗在局部发达的非小细胞肺癌中的疗效.
- 为了确定非小细胞肺癌的新辅助治疗后的手术挑战和考虑因素.
主要方法:
- 对非小细胞肺癌新辅助免疫疗法和化疗方案的当前文献的综述.
- 在涉及对非小细胞肺癌新辅助治疗的研究中报告的手术结果和挑战的分析.
主要成果:
- 病理完整响应率在17%至41%之间,与联合的新辅助疗法.
- 新辅助免疫治疗后的主要病理反应率在30%至65%之间.
结论:
- 新辅助疗法显著降低局部晚期非小细胞肺癌的瘤负担.
- 手术策略必须考虑潜在的状纤维化和改变的组织平面,并仔细选择患者的最小侵入性方法,并在必要时准备转换为开放性手术.
相关概念视频
01:27Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
01:30Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517